-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Silexion Therapeutics (NASDAQ:SLXN) shares rose 26.8% to $0.32 during Tuesday's pre-market session. The company's market cap stands at $1.3 million.
  • Summit Therapeutics (NASDAQ:SMMT) stock rose 16.34% to $18.01. The market value of their outstanding shares is at $12.3 billion.
  • SenesTech (NASDAQ:SNES) stock rose 15.48% to $0.73. The company's market cap stands at $3.4 million.
  • Iovance Biotherapeutics (NASDAQ:IOVA) shares increased by 10.55% to $12.15. The market value of their outstanding shares is at $4.9 billion.
  • Senti Biosciences (NASDAQ:SNTI) stock moved upwards by 9.67% to $0.34. The market value of their outstanding shares is at $9.6 million.
  • Crescent Biopharma (NASDAQ:CBIO) shares rose 8.6% to $15.78. The market value of their outstanding shares is at $539.7 million.

Losers

  • NewGenIvf Group (NASDAQ:NIVF) stock fell 67.6% to $0.11 during Tuesday's pre-market session.
  • uniQure (NASDAQ:QURE) shares fell 55.92% to $17.24. The company's market cap stands at $2.7 billion.
  • BeyondSpring (NASDAQ:BYSI) stock declined by 25.0% to $0.84. The company's market cap stands at $46.0 million.
  • ClearPoint Neuro (NASDAQ:CLPT) shares declined by 24.89% to $11.5. The company's market cap stands at $459.1 million.
  • Accuray (NASDAQ:ARAY) stock fell 11.81% to $0.26. The market value of their outstanding shares is at $35.8 million.
  • Kala Bio (NASDAQ:KALA) stock decreased by 11.11% to $0.4. The market value of their outstanding shares is at $8.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending